Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248958093> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4248958093 endingPage "S46" @default.
- W4248958093 startingPage "S45" @default.
- W4248958093 abstract "Despite available medications for dyslipidemia, many treated patients still have suboptimal lipid levels. The aim of this study was to examine the extent of residual dyslipidemia in United States adults. Of 2509 United States adults aged ≥18 years from the National Health and Nutrition Examination Survey (NHANES) 2009-2010, 1,129 (41.8% weighted) had hyperlipidemia on the basis of modified treatment guidelines for low-density lipoprotein (LDL) cholesterol according to risk category or pharmacologic treatment. Of these, 484 (42.4%) were treated with lipid-modifying therapy, and the proportions of subjects who still had LDL cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, or non-HDL cholesterol not at recommended levels were examined. In this cohort treated for hyperlipidemia, the mean age was 60.1 ± 14.9 years, and 52% were men. Only 36.5% of subjects receiving treatment for hyperlipidemia were at goal or normal levels for all 3 lipids (LDL cholesterol, HDL cholesterol, and triglycerides). LDL cholesterol remained higher than goal for 37.5% of subjects, 28.9% had low HDL cholesterol, and 36.3% had elevated triglycerides. One, 2, and 3 lipid parameters were at abnormal levels in 32.4%, 23.0%, and 8.2% of subjects, respectively; 36.5% had no lipid disorder. In addition, 38.6% of treated subjects were above non-HDL cholesterol goal, and even in those at LDL cholesterol goal, 12.9% were not at non-HDL cholesterol goal. Those with cardiovascular disease conditions had poorer goal attainment of LDL cholesterol, HDL cholesterol, and composite all lipids than those without cardiovascular disease. In conclusion, despite widely available treatments for dyslipidemia, many patients remain at suboptimal lipid levels, indicating need for greater adherence to lifestyle and medical therapies to address these gaps in the management of dyslipidemia." @default.
- W4248958093 created "2022-05-12" @default.
- W4248958093 creator A5022340856 @default.
- W4248958093 date "2019-06-01" @default.
- W4248958093 modified "2023-10-17" @default.
- W4248958093 title "Risk of acute pancreatitis after glucagon-like peptide-1 receptor agonists" @default.
- W4248958093 doi "https://doi.org/10.1016/j.pan.2019.05.115" @default.
- W4248958093 hasPublicationYear "2019" @default.
- W4248958093 type Work @default.
- W4248958093 citedByCount "0" @default.
- W4248958093 crossrefType "journal-article" @default.
- W4248958093 hasAuthorship W4248958093A5022340856 @default.
- W4248958093 hasConcept C126322002 @default.
- W4248958093 hasConcept C134018914 @default.
- W4248958093 hasConcept C152163801 @default.
- W4248958093 hasConcept C2778096610 @default.
- W4248958093 hasConcept C2778163477 @default.
- W4248958093 hasConcept C2778402494 @default.
- W4248958093 hasConcept C2779091943 @default.
- W4248958093 hasConcept C2779134260 @default.
- W4248958093 hasConcept C2779874844 @default.
- W4248958093 hasConcept C2780578515 @default.
- W4248958093 hasConcept C2908647359 @default.
- W4248958093 hasConcept C555293320 @default.
- W4248958093 hasConcept C71924100 @default.
- W4248958093 hasConcept C99454951 @default.
- W4248958093 hasConceptScore W4248958093C126322002 @default.
- W4248958093 hasConceptScore W4248958093C134018914 @default.
- W4248958093 hasConceptScore W4248958093C152163801 @default.
- W4248958093 hasConceptScore W4248958093C2778096610 @default.
- W4248958093 hasConceptScore W4248958093C2778163477 @default.
- W4248958093 hasConceptScore W4248958093C2778402494 @default.
- W4248958093 hasConceptScore W4248958093C2779091943 @default.
- W4248958093 hasConceptScore W4248958093C2779134260 @default.
- W4248958093 hasConceptScore W4248958093C2779874844 @default.
- W4248958093 hasConceptScore W4248958093C2780578515 @default.
- W4248958093 hasConceptScore W4248958093C2908647359 @default.
- W4248958093 hasConceptScore W4248958093C555293320 @default.
- W4248958093 hasConceptScore W4248958093C71924100 @default.
- W4248958093 hasConceptScore W4248958093C99454951 @default.
- W4248958093 hasLocation W42489580931 @default.
- W4248958093 hasOpenAccess W4248958093 @default.
- W4248958093 hasPrimaryLocation W42489580931 @default.
- W4248958093 hasRelatedWork W1520179443 @default.
- W4248958093 hasRelatedWork W1594116599 @default.
- W4248958093 hasRelatedWork W1982298768 @default.
- W4248958093 hasRelatedWork W2018645250 @default.
- W4248958093 hasRelatedWork W2023154173 @default.
- W4248958093 hasRelatedWork W2160613120 @default.
- W4248958093 hasRelatedWork W2327380077 @default.
- W4248958093 hasRelatedWork W2419201333 @default.
- W4248958093 hasRelatedWork W2152644235 @default.
- W4248958093 hasRelatedWork W2469373897 @default.
- W4248958093 hasVolume "19" @default.
- W4248958093 isParatext "false" @default.
- W4248958093 isRetracted "false" @default.
- W4248958093 workType "article" @default.